Zhang Qi, Yan Weiqun, Bai Yang, Xu Hao, Fu Changhao, Zheng Wenwen, Zhu Yingqiao, Ma Jie
School of Pharmaceutical Sciences, Jilin University, Jilin, P.R. China.
First Hospital of Jilin University, Jilin, P.R. China.
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8125. Epub 2021 Jun 29.
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the flow cytometric and western blotting data shown in Fig. 3A and C respectively, and the tumor images shown in Fig. 7A, bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 33: 448-456, 2015; DOI: 10.3892/or.2014.3591].
在本文发表后，一位关注此事的读者提醒编辑注意，图3A和C中所示的某些流式细胞术和蛋白质印迹数据，以及图7A中所示的肿瘤图像，与不同作者在其他文章中以不同形式出现的数据有意外的相似之处。由于上述文章中的一些有争议的数据在提交给本期刊之前已在其他地方发表，或已在考虑发表，编辑决定将本文从该期刊撤回。在与作者联系后，他们同意撤回该论文的决定。编辑就由此造成的不便向读者表示歉意。[原文发表于《肿瘤学报道》33: 448 - 456, 2015; DOI: 10.3892/or.2014.3591]
